Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries
Northwell Health · NCT06379425
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 70
- US sites recruiting
- 1
- Study start
- March 1, 2024
- Record last updated
- October 5, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a double-arm randomized control trial evaluating the impact of preoperative opioid-free analgesia on time to trial of void in ambulatory urogynecologic surgeries. The investigators hypothesize that receipt of acetaminophen, celecoxib and gabapentin preoperatively versus acetaminophen alone will reduce the time to trial of void in patients undergoing same-day minor urogynecologic procedures.
Being studied: Acetaminophen; Celecoxib; Gabapentin
Conditions: Pain, Postoperative; Postoperative Pain, Acute
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- All female patients over 18 years of age from the Northwell Health urogynecology offices in Bay Shore, Syosset, and Huntington, NY who are undergoing transvaginal minor urogynecologic surgery (midurethral sling, periurethral bulking injections, anterior repair, posterior repair, and perineorrhaphy) at South Shore Surgery Center
- In good general health as evidenced by medical history
- Ability to take oral medication and be willing to adhere to the study intervention
- Patients may be English or Spanish-speaking and must be able to provide informed consent
Exclusion Criteria
- Pregnancy or lactation
- Younger than age 18
- Known allergic reactions to acetaminophen, celecoxib or gabapentin or any components within the medication formulation
- Patients with Myasthenia Gravis, renal disease with CrCl \< 50, seizure disorder, substance use disorder, anaphylaxis and angioedema to gabapentin, Drug reaction with Eosinophilia and Systemic Symptoms (DRESS), driving impairment, increased seizures suicidal behavior and respiratory depression.
- Patients with a , history of asthma, urticaria, or other allergic type reactions after taking aspirin or other NSAIDS or DRESS, history of gastric bypass surgery, heart failure, active GI ulcer, active GI bleeding, inflammatory bowel disease, cerebrovascular bleeding, liver impairment/hepatic disease, hyperkalemia.
- Patients with compromised renal function who are notable to receive NSAIDs
- Patients with significant cardiovascular disease, such as patients with heart failure
- Patient with recent evidence of worsening fluid retention
- Both non-English and non-Spanish speaking patients
- Urogynecologic surgeries for apical repair (sacrocolpopexy, uterosacral ligament suspension, sacrospinous ligament suspension, colpocleisis)
- Current use of illicit substances (cocaine, non-prescription opioids, marijuana)
- Current use of gabapentin as home medication
Recruiting US locations
Northwell Health South Shore Surgery Center
Bay Shore, NY 11706
Site contact: Kathleen R Catalano, MSN, RN-BC · 631-647-5550 · kcatalano@southshoresurg.com
Similar studies in New York
All pain studies in New York →- RecruitingHealthy volunteersPhase 1
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
State University of New York - Upstate Medical University
- Location
- Syracuse, NY
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Brooklyn, NY + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
DiscGenics, Inc.
- Location
- New York, NY + 29 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
Boston Scientific Corporation
- Location
- The Bronx, NY + 6 other US sites
- Eligibility basics
- Ages 18+